Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Receivables - Other (2023 - 2025)

Basel Medical (BMGL) posted Receivables - Other of -$1.4 million for Q4 2025, down 1425.55% sequentially from $103089.4 in Q2 2025, and down 112.94% YoY from $10.6 million in Q4 2024.

Analysis

Basel Medical (BMGL) Receivables - Other (2023 - 2025) Analysis & Trends

Basel Medical has reported Receivables - Other for 2 years, with the latest figure at -$1.4 million in Q4 2025.

  • Quarterly Receivables - Other fell 112.94% year-over-year to -$1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.4 million (down 112.94% YoY) and the FY2025 annual result came in at $105502.0, down 98.7% from the prior year.
  • Receivables - Other slipped to -$1.4 million in Q4 2025 per BMGL's latest filing, from $103089.4 in the prior quarter.
  • Over five years, Receivables - Other peaked at $10.6 million in Q4 2024 and troughed at -$1.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.32 Bn 88.30 Bn 15.19 Bn
2 Tenet Healthcare 22.14 Bn 19.97 Bn 4.45 Bn
3 Encompass Health 12.05 Bn 11.91 Bn 1.34 Bn
4 Davita 11.89 Bn 11.21 Bn 1.16 Bn
5 Universal Health Services 10.10 Bn 9.96 Bn 3.29 Bn
6 Ensign 9.89 Bn 9.57 Bn 306.24 Mn
7 Chemed 6.85 Bn 6.81 Bn 221.47 Mn
8 Pacs 6.75 Bn 6.59 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 350,000.00
Jun 30, 2025 103,089.42
Dec 31, 2024 10.56 Mn
Jun 30, 2024 157,910.08
Dec 31, 2023 691,801.00